Cardiovascular DiseasesNCT05634239
Senior Health Clinic Study
A study testing Health Education in people with Cardiovascular Diseases and Dementia, run by University of Turku at 1 site in Finland.
Trial summary
Turku Senior Health Clinic study The Turku Senior Health Clinic Study was targeted to 75-year-old citizens with an underlying idea that at that age it would be almost the last moment to nudge people towards healthy lifestyle and taking care of their health and functional ability to maintain independent living. Read more about this study
- Who is it for?
- Ages 75 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Cardiovascular Diseases, Dementia, Frailty
- What is being tested?
- Health Education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 2,500 participants
- Where
- 1 siteFinland
- Study dates
- 2 Jan 2020to 31 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 75 to 75 years
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- citizens of Turku
- home-dwelling
Who cannot join
- use of munical home care
Trial locations and contacts
1 site in 1 country.
Finland1 site, 1 recruiting
- Recruiting
University of Turku
Turku, University of Turku, FI-20700
Marika Salminen, majosa@utu.fi
About this study
Official title: Senior Health Clinic for 75-year-old Home-dwelling Finns
Turku Senior Health Clinic study The Turku Senior Health Clinic Study was targeted to 75-year-old citizens with an underlying idea that at that age it would be almost the last moment to nudge people towards healthy lifestyle and taking care of their health and functional ability to maintain independent living.
The short-term aims of the Turku Senior Health Clinic Study are to survey health and functional statuses and prevalence of specified risk factors for CVDs, dementia, frailty, and functional decline of 75-year-old independently home-dwelling citizens of the city of Turku. The aims also include assessment the frequency of follow-up treatments needed, and recommendations given for lifestyle changes and evidence-based drug treatment, as well as fulfillment of these recommendations. Also, participants feedback on the Turku Senior Health Clinic will be assessed. In addition, based on the results, recommendation for the content and implementation of preventive health clinic targeted to older people will be provided. The long-term aim of the research project is to assess the effects of the Turku Senior Health Clinic on the need of institutional care and home care as well as the cost-effectiveness of the clinic during the 10-year follow-up. For this purpose, participants of the Senior Health Clinic Study will be compared to that of non-participants and earlier cohorts of 75-year-olds in terms of the use of home care and institutional care.
- Conditions
- Cardiovascular Diseases, Dementia, Frailty
- Being tested
- Health Education
- Keywords
- Health Clinic, Prevention, Home-dwelling, Older people, Functional ability
- Medical subject headings
- Cardiovascular Diseases, Dementia, Frailty
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Health EducationBehavioural
Interview, clinical examination and health education conducted by the clinic nurse.
Appointment with the physiotherapist including the assessment of physical functioning, use of assistive mobility devices, and amount of help needed in activities of daily living.
| Study group | Role | What they receive |
|---|---|---|
| Health check | Experimental | Not described Receives: Behavioral: Health Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Use of home care and institutional care.
Use of the municipal home care and institutional care among participant, non-participants and earlier cohorts from local registers.
Measured: 10 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Dec 2022
- Study start2 Jan 2020
- Primary completion31 Dec 2023 (estimated)
- Study completion31 Dec 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Cardiovascular DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 2,500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Turku
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Marika Salminen, University of Turku
- Investigators
- Laura Viikari, Study director, University of Turku
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05634239
- Sponsor's protocol ID
- 87/1801/2019
- Status last verified
- Nov 2022
- First submitted
- 21 Nov 2022
- Last updated
- 2 Dec 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Salminen M, Kummel M, Koskenniemi J, Vahlberg T, Viitanen M, Korhonen P, Viikari L. Sex differences in the secondary and primary prevention of cardiovascular diseases among 75-year-olds in Southwest Finland: a population-based study. BMC Prim Care. 2026 Jun 24. doi: 10.1186/s12875-026-03440-0. Online ahead of print.
PubMed 42337719Salminen M, Luther-Tontasse E, Koskenniemi J, Vahlberg T, Wuorela M, Viitanen M, Korhonen P, Viikari L. Factors contributing to self-rated health in community-dwelling independent 75-year-old Finns: a population-based cross-sectional cohort study. BMC Geriatr. 2025 Mar 1;25(1):141. doi: 10.1186/s12877-025-05794-z.
PubMed 40025413Salminen M, Stenholm S, Koskenniemi J, Korhonen P, Pitkanen T, Viikari P, Wuorela M, Viitanen M, Viikari L. Senior Health Clinic for 75-year-old home-dwelling Finns - study design, clinic protocol and non-response analysis. BMC Health Serv Res. 2023 Mar 2;23(1):210. doi: 10.1186/s12913-023-09199-9.
PubMed 36864394
Study at a glance
From the registry record, last updated by the sponsor on 2 Dec 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Senior Health Clinic for 75-year-old Home-dwelling Finns
- ClinicalTrials.gov ID
- NCT05634239
- Acronym / sponsor ID
- 87/1801/2019
- Conditions
- Cardiovascular Diseases, Dementia, Frailty
- Keywords
- Health Clinic, Prevention, Home-dwelling, Older people, Functional ability
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 2,500 participants (estimated)
- Lead sponsor
- University of TurkuUniversity, hospital or other
- Study start
- 2 Jan 2020 (actual)
- Primary completion
- 31 Dec 2023 (estimated)
- Study completion
- 31 Dec 2023 (estimated)
- First posted
- 2 Dec 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Turku Senior Health Clinic study The Turku Senior Health Clinic Study was targeted to 75-year-old citizens with an underlying idea that at that age it would be almost the last moment to nudge people towards healthy lifestyle and taking care of their health and functional ability to maintain independent living.
The short-term aims of the Turku Senior Health Clinic Study are to survey health and functional statuses and prevalence of specified risk factors for CVDs, dementia, frailty, and functional decline of 75-year-old independently home-dwelling citizens of the city of Turku. The aims also include assessment the frequency of follow-up treatments needed, and recommendations given for lifestyle changes and evidence-based drug treatment, as well as fulfillment of these recommendations. Also, participants feedback on the Turku Senior Health Clinic will be assessed. In addition, based on the results, recommendation for the content and implementation of preventive health clinic targeted to older people will be provided. The long-term aim of the research project is to assess the effects of the Turku Senior Health Clinic on the need of institutional care and home care as well as the cost-effectiveness of the clinic during the 10-year follow-up. For this purpose, participants of the Senior Health Clinic Study will be compared to that of non-participants and earlier cohorts of 75-year-olds in terms of the use of home care and institutional care.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Health check | Experimental | Behavioral: Health Education |
Who may qualify
- Ages
- 75 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (2 listed)
- citizens of Turku
- home-dwelling
Key exclusion criteria (1 listed)
- use of munical home care
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Health EducationInterview, clinical examination and health education conducted by the clinic nurse. Appointment with the physiotherapist including the assessment of physical functioning, use of assistive mobility devices, and amount of help needed in activities of daily living. | Behavioural | Health check |
Primary outcome
Use of home care and institutional care.
Time frame: 10 year
Use of the municipal home care and institutional care among participant, non-participants and earlier cohorts from local registers.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Dec 2022.
- Derived from this study: PubMed 42337719Salminen M, Kummel M, Koskenniemi J, Vahlberg T, Viitanen M, Korhonen P, Viikari L. Sex differences in the secondary and primary prevention of cardiovascular diseases among 75-year-olds in Southwest Finland: a population-based study. BMC Prim Care. 2026 Jun 24. doi: 10.1186/s12875-026-03440-0. Online ahead of print.
- Derived from this study: PubMed 40025413Salminen M, Luther-Tontasse E, Koskenniemi J, Vahlberg T, Wuorela M, Viitanen M, Korhonen P, Viikari L. Factors contributing to self-rated health in community-dwelling independent 75-year-old Finns: a population-based cross-sectional cohort study. BMC Geriatr. 2025 Mar 1;25(1):141. doi: 10.1186/s12877-025-05794-z.
- Derived from this study: PubMed 36864394Salminen M, Stenholm S, Koskenniemi J, Korhonen P, Pitkanen T, Viikari P, Wuorela M, Viitanen M, Viikari L. Senior Health Clinic for 75-year-old home-dwelling Finns - study design, clinic protocol and non-response analysis. BMC Health Serv Res. 2023 Mar 2;23(1):210. doi: 10.1186/s12913-023-09199-9.
- Individual participant dataSharing planned: No
Related trials for Cardiovascular Diseases
RecruitingPhase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
RecruitingPhase 1/2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease
Active, not recruiting
ARIADNE Clinical Trial
Persistent Atrial Fibrillation
Not yet recruiting
Closed-Loop SCS-BCI for Post-Stroke Hemiplegia
Stroke, Motor Dysfunction
Active, not recruitingPhase 1
A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
Familial Erythromelalgia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Laura Viikari study director
University of Turku
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Health Education in people with Cardiovascular Diseases and Dementia, run by University of Turku at 1 site in Finland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 2 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Marika Salminen (+358 40 8364115, majosa@utu.fi), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Use of home care and institutional care. (time frame: 10 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05634239, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Dec 2022.